State of Wisconsin Investment Board
AVIR icon

State of Wisconsin Investment Board’s Atea Pharmaceuticals AVIR Stock Holding History

State of Wisconsin Investment Board’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$552K Buy
118,757
+18,954
+19% +$94.3K ﹤0.01% 2062
2026
Q1 		$537K Buy
99,803
+8,558
+9% +$39.3K ﹤0.01% 1960
2025
Q4 		$326K Sell
91,245
-15,721
-15% -$50K ﹤0.01% 2138
2025
Q3 		$310K Sell
106,966
-2,374
-2% -$8.11K ﹤0.01% 2092
2025
Q2 		$394K Buy
109,340
+11,213
+11% +$33.4K ﹤0.01% 1962
2025
Q1 		$293K Sell
98,127
-17,873
-15% -$55.8K ﹤0.01% 1977
2024
Q4 		$389K Buy
116,000
+6,800
+6% +$22.6K ﹤0.01% 1909
2024
Q3 		$366K Sell
109,200
-34,100
-24% -$124K ﹤0.01% 1991
2024
Q2 		$474K Buy
143,300
+14,400
+11% +$53.7K ﹤0.01% 1850
2024
Q1 		$521K Sell
128,900
-1,000
-0.8% -$3.91K ﹤0.01% 1734
2023
Q4 		$396K Buy
129,900
+6,700
+5% +$20.3K ﹤0.01% 1887
2023
Q3 		$370K Sell
123,200
-34,900
-22% -$119K ﹤0.01% 1954
2023
Q2 		$591K Sell
158,100
-32,875
-17% -$123K ﹤0.01% 1746
2023
Q1 		$640K Sell
190,975
-24,277
-11% -$98.5K ﹤0.01% 1741
2022
Q4 		$1.04M Buy
215,252
+34,185
+19% +$173K ﹤0.01% 1485
2022
Q3 		$1.03M Buy
181,067
+5,525
+3% +$42.3K ﹤0.01% 1531
2022
Q2 		$1.25M Buy
175,542
+11,742
+7% +$80.2K ﹤0.01% 1511
2022
Q1 		$1.18M Buy
163,800
+80,200
+96% +$545K ﹤0.01% 1605
2021
Q4 		$747K Hold
83,600
– – ﹤0.01% 1542
2021
Q3 		$2.93M Hold
83,600
– – 0.01% 1195
2021
Q2 		$1.8M Buy
83,600
+63,500
+316% +$1.91M ﹤0.01% 1315
2021
Q1 		$1.24M Hold
20,100
– – ﹤0.01% 1317
2020
Q4 		$840K Buy
+20,100
New +$648K ﹤0.01% 1372

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of Wisconsin Investment Board's AVIR Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Atea Pharmaceuticals (AVIR) stake by 19% in Q2 2026, buying an estimated $94.3K and bringing the position to 118,757 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

State of Wisconsin Investment Board first reported a position in AVIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.93M in Q3 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • State of Wisconsin Investment Board held 118,757 shares of Atea Pharmaceuticals worth $552K as of Q2 2026.
  • State of Wisconsin Investment Board bought 18,954 Atea Pharmaceuticals shares in Q2 2026, an estimated $94.3K.
  • Atea Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #2062 holding.
  • State of Wisconsin Investment Board first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • State of Wisconsin Investment Board's Atea Pharmaceuticals position peaked at $2.93M in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.